Should children be deprived of the benefits of flouroquinolones?
dc.contributor.author | De Silva, D.G.H. | |
dc.date.accessioned | 2016-01-14T08:39:38Z | |
dc.date.available | 2016-01-14T08:39:38Z | |
dc.date.issued | 1994 | |
dc.identifier.citation | The Ceylon Medical Journal, 39(2)pp.113-114 | |
dc.identifier.uri | https://dl.nsf.gov.lk/handle/1/20436 | |
dc.publisher | The Sri Lanka Medical Association:Colombo | |
dc.subject | Medical Sciences | |
dc.subject | Antimicrobial chemotheraphy | |
dc.subject | Drug toxicology | |
dc.subject | Arthropathy | |
dc.subject | Paediatrics | |
dc.subject | Quinolone nalidixic | |
dc.subject | Pharmacology | |
dc.title | Should children be deprived of the benefits of flouroquinolones? | |
dc.type | Article |